159 related articles for article (PubMed ID: 18651339)
1. Improvement of subjective well-being and enduring symptomatic remission, a 5-year follow-up of first episode schizophrenia.
de Haan L; Nimwegen Lv; Amelsvoort Tv; Dingemans P; Linszen D
Pharmacopsychiatry; 2008 Jul; 41(4):125-8. PubMed ID: 18651339
[TBL] [Abstract][Full Text] [Related]
2. Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders: valid predictors of symptomatic response and remission?
Schennach-Wolff R; Jäger M; Obermeier M; Schmauss M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Kühn KU; Lemke MR; Rüther E; Klingberg S; Gastpar M; Seemüller F; Möller HJ; Riedel M
World J Biol Psychiatry; 2010 Aug; 11(5):729-38. PubMed ID: 20380620
[TBL] [Abstract][Full Text] [Related]
3. Symptomatic remission and cognitive impairment in first-episode schizophrenia: a prospective 3-year follow-up study.
Chang WC; Ming Hui CL; Yan Wong GH; Wa Chan SK; Ming Lee EH; Hai Chen EY
J Clin Psychiatry; 2013 Nov; 74(11):e1046-53. PubMed ID: 24330905
[TBL] [Abstract][Full Text] [Related]
4. Testosterone in first-episode schizophrenia.
Cesková E; Prikryl R; Kaspárek T
Neuro Endocrinol Lett; 2007 Dec; 28(6):811-4. PubMed ID: 18063925
[TBL] [Abstract][Full Text] [Related]
5. Influencing factors and predictors of early improvement in the acute treatment of schizophrenia and schizophrenia spectrum disorder.
Schennach-Wolff R; Meyer S; Seemüller F; Jäger M; Schmauss M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Möller HJ; Riedel M
J Psychiatr Res; 2011 Dec; 45(12):1639-47. PubMed ID: 21862035
[TBL] [Abstract][Full Text] [Related]
6. The relationship between depressive symptoms and subjective well-being in newly admitted patients with schizophrenia.
Kim JH; Ann JH; Kim MJ
Compr Psychiatry; 2010; 51(2):165-70. PubMed ID: 20152297
[TBL] [Abstract][Full Text] [Related]
7. Patient-based and clinician-based support for the remission criteria in schizophrenia.
Docherty JP; Bossie CA; Lachaux B; Bouhours P; Zhu Y; Lasser R; Gharabawi GM
Int Clin Psychopharmacol; 2007 Jan; 22(1):51-5. PubMed ID: 17159460
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for medication non-adherence in patients with first episode schizophrenia and related disorders; a prospective five year follow-up.
de Haan L; van Amelsvoort T; Dingemans P; Linszen D
Pharmacopsychiatry; 2007 Nov; 40(6):264-8. PubMed ID: 18030650
[TBL] [Abstract][Full Text] [Related]
9. Depression during an acute episode of schizophrenia or schizophreniform disorder and its impact on treatment response.
Jäger M; Riedel M; Schmauss M; Pfeiffer H; Laux G; Naber D; Gaebel W; Huff W; Schmidt LG; Heuser I; Buchkremer G; Kühn KU; Rüther E; Hoff P; Gastpar M; Bottlender R; Strauss A; Möller HJ
Psychiatry Res; 2008 Apr; 158(3):297-305. PubMed ID: 18280582
[TBL] [Abstract][Full Text] [Related]
10. [Subjective view of positive symptoms and quality of life in patients with schizophrenia].
Karow A; Schäfer I; Hirdes F; Osterwald C; Naber D
Psychiatr Prax; 2008 Sep; 35(6):286-93. PubMed ID: 18504688
[TBL] [Abstract][Full Text] [Related]
11. Predictive validity of proposed remission criteria in first-episode schizophrenic patients responding to antipsychotics.
Wunderink L; Nienhuis FJ; Sytema S; Wiersma D
Schizophr Bull; 2007 May; 33(3):792-6. PubMed ID: 16894026
[TBL] [Abstract][Full Text] [Related]
12. Psychometric properties of the Subjective Well-Being Under Neuroleptics scale and the Subjective Deficit Syndrome Scale.
de Haan L; Weisfelt M; Dingemans PM; Linszen DH; Wouters L
Psychopharmacology (Berl); 2002 Jun; 162(1):24-8. PubMed ID: 12107613
[TBL] [Abstract][Full Text] [Related]
13. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
14. Correlation of subjective well-being in schizophrenic patients with gait parameters, expert-rated motor disturbances, and psychopathological status.
Putzhammer A; Perfahl M; Pfeiff L; Hajak G
Pharmacopsychiatry; 2005 May; 38(3):132-8. PubMed ID: 15902585
[TBL] [Abstract][Full Text] [Related]
15. Remission in schizophrenia: one-year Italian prospective study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorder.
Rossi A; Bagalà A; Del Curatolo V; Scapati F; Bernareggi MM; Giustra MG;
Hum Psychopharmacol; 2009 Oct; 24(7):574-83. PubMed ID: 19790173
[TBL] [Abstract][Full Text] [Related]
16. Remission after first-episode schizophrenia: results of a long-term follow-up.
Üçok A; Serbest S; Kandemir PE
Psychiatry Res; 2011 Aug; 189(1):33-7. PubMed ID: 21196051
[TBL] [Abstract][Full Text] [Related]
17. Early- and delayed antipsychotic response and prediction of outcome in 528 severely impaired patients with schizophrenia treated with amisulpride.
Lambert M; Schimmelmann BG; Naber D; Eich FX; Schulz H; Huber CG; Karow A
Pharmacopsychiatry; 2009 Nov; 42(6):277-83. PubMed ID: 19924588
[TBL] [Abstract][Full Text] [Related]
18. Performance of the Italian version of the subjective well-being under neuroleptic (SWN) scale in schizophrenic outpatients.
Balestrieri M; Giaroli G; Mazzi M; Bellantuono C
Pharmacopsychiatry; 2006 May; 39(3):81-4. PubMed ID: 16721695
[TBL] [Abstract][Full Text] [Related]
19. Interictal psychoses in comparison with schizophrenia--a prospective study.
Tadokoro Y; Oshima T; Kanemoto K
Epilepsia; 2007 Dec; 48(12):2345-51. PubMed ID: 17666070
[TBL] [Abstract][Full Text] [Related]
20. Achieving symptomatic remission in out-patients with schizophrenia--a naturalistic study with quetiapine.
Wobrock T; Köhler J; Klein P; Falkai P
Acta Psychiatr Scand; 2009 Aug; 120(2):120-8. PubMed ID: 19392812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
